After a bitter and divisive re-election campaign, George W. Bush is set to lead the US for the next four years — and that includes directing its science policy. For life science researchers, this means you shouldn’t expect any major flip-flops on issues such as drug reimportation, funding for controversial biological research involving embryos, or major shifts in funding priorities.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.